Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia

Status Completed

Clinical Trial Summary

Idiopathic Macular Telangiectasia is characterized by incompetent and dilated retinal capillaries in the foveolar region of unknown cause for retinal telangiectasia.

In Idiopathic Macular Telangiectasia, proliferative changes occur in the deep retinal capillary network, leading to intraretinal neovascularization that, unlike in age-related macular degeneration, seems to be retinal rather than choroidal in origin. Before the hemorrhagic and fibrotic state, these vessels may lead to exudation and decrease in the visual acuity. Long-term visual prognosis in patients with this complication may be poor and treatment with laser photocoagulation is unproven. Although newly reported treatment, by photodynamic therapy for neovascular membrane associated with Idiopathic Macular Telangiectasia, may show vision and angiographic stability in a few cases, the improvement may be transient. VEGF has been implicated as the major angiogenic stimulus responsible for neovascularization in AMD, ensuing specific anti-VEGF treatment in these cases.

The purpose of the study is to evaluate intravitreal injection of bevacizumab (1.25mg/0.05ml) in the treatment of Idiopathic Macular Telangiectasia.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00451763
Study type	Interventional
Source	University of Sao Paulo
Contact
Status	Completed
Phase	Phase 3
Start date	January 2006
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00431691` - Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.	Phase 4
Completed	`NCT01157338` - Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization	N/A
Completed	`NCT03326908` - Description of the Interdigitation Retinal Area by SD-OCT: An Exploratory Study	N/A
Completed	`NCT04794634` - Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers	N/A
Recruiting	`NCT05747742` - Effect of Different Intensities of Repeated Low-Level Red-Light Therapy on Choroidal and Retinal Blood Flow Among Adults	N/A
Completed	`NCT00709423` - Effects of Moxaverine and Placebo on Ocular Blood Flow	Phase 2
Completed	`NCT00814008` - The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp	Phase 2
Terminated	`NCT04408677` - Normative Data Collection Study of the Zilia Ocular for the Measurement of Oxygen Saturation in the Retina	N/A
Completed	`NCT00706927` - Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension	N/A
Recruiting	`NCT02614625` - Spectral-domain Optical Coherence Tomography of the Eye	N/A
Completed	`NCT00431730` - Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?	N/A
Completed	`NCT03197493` - Extension, Carbidopa-levodopa in Neovascular AMD	Phase 2
Not yet recruiting	`NCT05796856` - Effect of Different Wavelengths of Repeated Low-Level Light Therapy on Choroidal and Retinal Blood Flow Among Adults	N/A
Completed	`NCT00431548` - Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)	N/A